You are here

Article Text

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Sleep-related eating disorder with mirtazapine
  1. Dhanya Shinith1,
  2. Anand Mathilakath1,
  3. Da-In Kim2,
  4. Biren Patel2
  1. 1General Adult Psychiatry, Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, Surrey, UK
  2. 2Ashford and St Peters Hospitals NHS Foundation Trust, Chertsey, UK
  1. Correspondence to Dr Dhanya Shinith, drdhanyashinith{at}gmail.com

Summary

Sleep-related eating disorder (SRED) is classified within parasomnia and is characterised by recurrent episodes of abnormal, dysfunctional eating during sleep. This report describes a case of SRED in a 19-year-old woman admitted to the psychiatric ward with worsening anxiety, low mood and suicidal ideation. She was started on low-dose mirtazapine for mood stabilisation and, following an incremental increase to 30 mg, she developed nocturnal binge eating of which she retained only partial memory on waking. She developed adverse health consequences as a result of these recurrent episodes. The subject’s symptoms were relieved rapidly following reduction of the dose of mirtazapine back to 15 mg.

  • psychiatry (drugs and medicines)
  • psychiatry
  • drugs: psychiatry
  • sleep disorders

https://doi.org/10.1136/bcr-2018-224676

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors DS contributed to the conception of the work and drafting the article. D-IK and BP contributed with obtaining history, reviewing the patient and also assisted DS in drafting the article. AM did critical revision of the article.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.